ERBB2 and breast carcinoma: To demonstrate TUSV-int’s performance on a true example of joint bulk DNA-seq and scRNA-seq data, we selected one dataset from an ER/HER2-positive breast cancer patient (BC03) among 11 patients studied by Chung et al. [2].